Next generation sequencing (NGS) is becoming one of the most important technologies in modern healthcare and life sciences. It allows researchers to analyze DNA and RNA much faster than traditional sequencing methods, making it easier to study genetic diseases, cancer, infectious diseases, and personalized medicine.
The global next generation sequencing sector was valued at USD 12.5 billion in 2025 and is expected to reach USD 15.22 billion in 2026. It is projected to grow to USD 89.4 billion by 2035, with a CAGR of 21.74%.
Why Is NGS Growing So Quickly?
The biggest driver is the rising demand for precision medicine. Doctors and researchers are increasingly using genetic information to diagnose diseases earlier and select treatments that match a patient’s unique genetic profile.
Several factors are supporting this growth:
- Growing adoption of precision medicine
- Rising demand for cancer genomics
- Increasing investment in genomic research
- Expansion of population sequencing programs
- Growing use of AI in genomic analysis
- Declining cost of sequencing technologies
How AI Is Changing Genomics
NGS generates enormous amounts of genetic data, and analyzing it manually can take significant time. Artificial intelligence is helping researchers identify genetic variants, improve diagnostic accuracy, and speed up data interpretation. AI is also reducing errors in sequencing workflows and supporting the discovery of new biomarkers for complex diseases.
Key Applications
Oncology remains the largest application for NGS because it helps identify genetic mutations that drive cancer growth. The technology is also widely used in rare disease diagnosis, reproductive health, infectious disease surveillance, pharmacogenomics, and drug discovery. As sequencing becomes more affordable, its use is expanding across both research and clinical settings.
Regional Outlook
North America continues to lead due to advanced healthcare infrastructure, strong genomics research, and major investments in biotechnology. Asia Pacific is expected to grow the fastest, supported by large-scale genomic initiatives, improving research capabilities, and increasing adoption of sequencing technologies in countries like China and India.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/5344
Future Outlook
Next generation sequencing is moving beyond research laboratories into everyday clinical practice. Faster sequencing platforms, AI-powered bioinformatics, and lower testing costs are making genomic analysis more accessible than ever. As healthcare becomes increasingly personalized, NGS is expected to play a central role in improving diagnosis, accelerating drug development, and delivering more targeted treatments for patients worldwide.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium